Provenance
Source & edition record
This page records where the text came from, what changed in presentation, and what remains unverified.
Bibliographic source
- Work
- Efficacy and safety of recombinant von Willebrand factor in on-demand treatment of children with von Willebrand disease: up to 4 years of phase 3/3b follow-up
- Authors
- Shayla Bergmann, Sanjay Ahuja, Canan Albayrak, Marjon H. Cnossen, Amy L. Dunn, Veerle Labarque, Matteo Luciani, Christoph Male, Eric S. Mullins, Sophie Susen, Pascual Marco Vera, Ali G. Mokdad, Yi Wang, Josh Weng, and Jingmei Zhang
- First publication
- Research and Practice in Thrombosis and Haemostasis, 2026, vol. 10, no. 5, pp. 106817. DOI: 10.1016/j.rpth.2026.106817
- Accessed
- 2026-08-24
- Verification
- source-compared
- Source snapshot SHA-256
62fff62d43ed3c9bd651313d549926d1eb1aa9fd07cf9d440e281560dead5b6f
Transformations
Rights status
open-license. CC BY source edition from PubMed Central. View the rights record ↗